article Open Access
Management of asymptomatic hyperuricemia at primary care
International Journal of Midwifery and Nursing Practice · 2019 · Vol. 2(2) · pp. 14–16
Ayesha Rashid✉(Dubai Health Authority)Dileep Kumar(Dubai Health Authority)
Abstract
Asymptomatic Hyperuricemia (AHU) is a condition with abnormal serum uric acid levels, without clinical signs or symptoms. AHU is a risk factor of various clinical conditions as hypertension, renal diseases, metabolic syndrome, stroke etc. It is controversial that AHU should be treated with Uric acid lowering therapy (ULT), and most of the latest guidelines do not suggest the use of ULT. However, non-pharmaceutical measures can help in management of this condition.
Gout, Hyperuricemia, Uric AcidMuscle and Compartmental DisordersCase Reports on HematomasHyperuricemiaAsymptomaticMedicineUric acidStroke (engine)Metabolic syndromeInternal medicinePrimary careIntensive care medicineObesity
Citations
0
FWCI
0.00
field-weighted impact
References
19
Percentile
35%
vs. same field & year
References
Prevalence of gout and hyperuricemia in the US general population: The National Health and Nutrition Examination Survey 2007-2008
Arthritis & Rheumatism · 2011 · 1,794 citations
Prevalence of Hyperuricemia and Gout in Mainland China from 2000 to 2014: A Systematic Review and Meta-Analysis
BioMed Research International · 2015 · 635 citations
2016 updated EULAR evidence-based recommendations for the management of gout
Annals of the Rheumatic Diseases · 2016 · 1,628 citations
Hyperuricemia, Acute and Chronic Kidney Disease, Hypertension, and Cardiovascular Disease: Report of a Scientific Workshop Organized by the National Kidney Foundation
American Journal of Kidney Diseases · 2018 · 628 citations
Citation Network
How this paper connects to the literature. Drag to explore, click any node to open that paper.